Jump to navigation
STEM CELLS | STEM CELLS Translational Medicine
For the past 30 years, umbilical cord blood has been a viable graft source option for hematopoietic cell transplant for both pediatric and adult patients with hematologic disorders.
The limited numbers of cord blood hematopoietic stem cells (HSCs) collected at birth remains a critical limiting factor in the use of cord blood for HSC transplantation.
A new STEM CELLS Translational Medicine article from researchers led by
A recent STEM CELLS article from researchers led by
An exciting new STEM CELLS Translational Medicine article from the laboratories of Scott D. Olson and Charles S.
Trial provides evidence for the safety and feasibility of cord blood cell infusion after birth in preterm neonates to reduce the rate of complications
Successful pre‐clinical studies in animal models heralded the increasing clinical interest of cord blood in regenerative therapy.
A recent STEM CELLS Translational Medicine article reporting on a prospective non-r
Intraventricular hemorrhage (IVH), a severe complication of preterm birth leading to hydrocephalus, cerebral palsy, and mental retardation, suffers from a lack of therapeutic approaches.
Early intravenous infusion of umbilical cord stem cells fosters long‐term improvements in tissue and functional readouts following spinal cord injury
The Stem Cells Portal is a shared platform for the STEM CELLS and STEM CELLS Translational Medicine sister journals, providing up-to-the-minute coverage of the latest research from bench science and developments to clinical applications.
Copyright © 2020